IFNγ-MSC-sEVs reduced thickness, erythema, and scales of skin lesions, exhausted Th17 cells, increased Th2 cells, and reduced inflammatory cytokines.IFNγ-MSC-sEVs significantly improved the delivery efficiency and stability of ASO-210. The gene discussed is IFNG; the disease is Erythema.